Transitions in PAH Therapy is organized by Washington University School of Medicine in St. Louis.

Publication Date: Jul 1, 2020
Expiration Date: Jun 30, 2021

Target Audience:
This course is designed for pulmonologists, intensivists, cardiologists, rheumatologists, internists, critical care physicians, primary care, nurses, nurse practitioners, physician assistants, pharmacists and other health professionals.

Credits: 0.5

American Medical Association (AMA Credit):
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™.

The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
• Summarize indications for transitioning between therapies for PAH.
• Determine the need to "step-up" therapy for patients not meeting comprehensive treatment goals.
• Appreciate unique pharmacologic aspects different prostacyclin pathway activators.
• Apply pre-transition criteria for safely "stepping down" in therapy.
• Describe how to determine success after transition.

Additional details will be posted as soon as information is available.

Intended Audience

Cardiology, Pulmonary Medicine

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


Washington University School of Medicine in St. Louis

View Organizer Details